Diz Gotham

@dgotham.bsky.social

This is a comprehensive investigation of patent abuse of a Keytruda & the best I've ever seen patent data visualisation of evergreening practices and the resulting thicket until 2046 - another extra twenty years of patent monopoly right h/t @clancyny.bsky.social

How Merck uses patents to help maintain Keytruda's exorbitant price - ICIJ

Explore the U.S. patents Merck deploys to stymie competition and keep revenues for its blockbuster cancer drug flowing as long as possible.

icij.org

ICIJ@icij.org · 4mo ago

#CancerCalculus: An ICIJ-led collaboration with 47 media partners in 37 countries reveals how Merck & Co. keeps the price of its lifesaving cancer drug Keytruda sky-high, locking out patients and squeezing health care systems worldwide. www.icij.org/investigatio...

IHME 2024 reports in the Discussion that "more than 50 million deaths averted by improving access to existing antimicrobials". But it doesn't report this figure anywhere in the Results or appendices. Any pointers to where this figure comes from highly appreciated! www.thelancet.com/journals/lan...

Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050

This study presents the first comprehensive assessment of the global burden of AMR from 1990 to 2021, with results forecasted until 2050. Evaluating changing trends in AMR mortality across time and lo...

thelancet.com